It may not be business as usual again as Sproxil, a US based company committed to protecting brands globally announced  how best  IBM technology will help pharmaceutical industry reduce drug counterfeiting by allowing consumers to verify the authenticity of prescriptions in seconds with their mobile phones.

Sproxil – at the ongoing Impact 2012 holding in Las Vegas, the United States of America, – announced that by  using IBM SmartCloud, is expected to  benefit  from the cost savings and scalability associated with a cloud environment while preserving the ability to take advantage of the security, existing applications, reliability, management and support services more typical of a private cloud.

With this collaboration with IBM, Sproxil is extending manufacturers’ ability to view and analyze real time consumer data to detect and prevent drug counterfeiting in developing countries, where 25 to 50 percent of medicines are believed to be counterfeit, costing the industry $$75 billion a year.